Dedeepya Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.50 Cr
as on 24-10-2024
- Company Age 10 Year, 10 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 43.16 Cr
as on 24-10-2024
- Satisfied Charges ₹ 6.80 Cr
as on 24-10-2024
- Revenue 353.14%
(FY 2023)
- Profit 860.06%
(FY 2023)
- Ebitda 276.77%
(FY 2023)
- Net Worth 88.17%
(FY 2023)
- Total Assets 212.59%
(FY 2023)
About Dedeepya Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹43.16 Cr. The company has closed loans amounting to ₹6.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahidhar Reddy, Manjula Dasari, Varun Reddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2014PTC096778
- Company No.
096778
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2014
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dedeepya Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varun Reddy  | Managing Director | 11-Dec-2014 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Preeti Reddy | Director | 05-Aug-2015 | Current |
| Mahidhar Reddy | Whole-Time Director | 11-Dec-2014 | Current |
| Manjula Dasari | Whole-Time Director | 11-Dec-2014 | Current |
| Niharika Kondakindi | Director | 11-Oct-2024 | Current |
Financial Performance and Corporate Structure Insights of Dedeepya Pharma.
Dedeepya Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 353.14% increase. The company also saw a substantial improvement in profitability, with a 860.06% increase in profit. The company's net worth Soared by an impressive increase of 88.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dedeepya Pharma?
In 2022, Dedeepya Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sri Rama Avenues Private LimitedActive 1 year 8 monthsMahidhar Reddy, Manjula Dasari and 2 more are mutual person
- Sri Rama Pharmaceutical Distributors Private LimitedActive 3 years 1 month
Mahidhar Reddy and Varun Reddy are mutual person
- Lilium Realties Private LimitedActive 4 months 27 days
Manjula Dasari and Preeti Reddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Dec 2023 | ₹1.57 Cr | Open |
Hdfc Bank Limited Creation Date: 10 Sep 2023 | ₹41.00 Cr | Open |
Hdfc Bank Limited Creation Date: 16 Apr 2023 | ₹5.90 M | Open |
How Many Employees Work at Dedeepya Pharma?
Unlock and access historical data on people associated with Dedeepya Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dedeepya Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dedeepya Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
